GlassScriptPhysician profile
Jeffrey Lombard
NPI 1669441705
$3,424.06
in general payments reported to CMS, 2019-2025
19 companies · $355 in 2025
The $355 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $522 · 2021: $738 · 2022: $877 · 2023: $487 · 2024: $274 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $805.58 | 2019-2024 | Xiaflex, Aveed, Edex |
| Astellas Pharma US INC | $618.98 | 2019-2024 | Xtandi, Myrbetriq |
| Axonics, INC. | $440.20 | 2020-2024 | Axonics |
| Endo USA, INC. | $175.12 | 2024-2025 | Xiaflex, Aveed, Edex |
| Boston Scientific Corporation | $171.26 | 2019-2023 | Spaceoar Vue System - 10ml, Spaceoar System, Greenlight Xps |
| Sumitomo Pharma America, INC. | $168.73 | 2023-2025 | Gemtesa, Orgovyx |
| Coloplast Corp | $165.97 | 2021-2022 | |
| Pfizer INC. | $145.59 | 2020-2021 | |
| Rochester Medical Corporation | $129.29 | 2022 | |
| Abbvie INC. | $102.77 | 2023-2025 | |
| Becton, Dickinson and Company | $81.13 | 2025 | Magic3 Go Intermittent Urinary Catheter, Bard Urinary Drainage Bag |
| Allergan, INC. | $80.76 | 2019-2022 | |
| Myovant Sciences INC. | $76.10 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $74.46 | 2019-2025 | Bard Urinary Drainage Bag |
| Janssen Biotech, INC. | $65.46 | 2025 | Erleada |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $63.80 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $29.27 | 2023-2025 | Trelstar |
| 180 Medical, INC. | $16.44 | 2024 | Gentlecath |
| Bayer Healthcare Pharmaceuticals INC. | $13.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lombard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.